Stella Xu
Director
Board of Directors
ARMO Biosciences
Japan
Biography
Dr. Stella Xu has over 20 years of experience in the biopharmaceutical industry. She is a Managing Director of Quan Capital, a life sciences venture fund with offices in China & the United States, and has deep expertise in cross board value creation and global investments. Prior to Quan, Stella was Vice President & Site Head of Roche Innovation Center Shanghai, and a core member of the global management team for Roche’s Immunology, Inflammation & Infectious Diseases Discovery and Translation Area. She led the integrated research and early development site in China to discover and develop innovative medicines for global patients. Stella also established the Roche Partnering office in Shanghai and managed business development and licensing activities in APAC (ex-Japan) from 2008 to 2012. Prior to her leadership roles in Asia, she managed global due diligence transaction activities and key alliances across disease areas in Roche Partnering US. Stella joined Roche from McKinsey where she led consulting engagements with healthcare clients in diverse functional areas. Earlier in her career, Stella worked in biotech drug discovery in oncology & inflammation. Stella received her Ph.D. in Immunology from Northwestern University, and her B.S. in Biophysics from Peking University.
Research Interest
Immunology, Oncology
